Phylogica Financials
| PH7 Stock | EUR 0.62 0.00 0.00% |
Phylogica |
Please note, the imprecision that can be found in Phylogica's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Phylogica Limited. Check Phylogica's Beneish M Score to see the likelihood of Phylogica's management manipulating its earnings.
| Foreign Associate | Germany |
| Instrument | Germany Stock View All |
| Exchange | Munich Exchange |
| Business Address | Harry Perkins Institute, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | pyctx.com |
| Phone | 61 8 6151 0992 |
| Currency | EUR - Euro |
You should never invest in Phylogica without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Phylogica Stock, because this is throwing your money away. Analyzing the key information contained in Phylogica's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Phylogica Key Financial Ratios
Phylogica's financial ratios allow both analysts and investors to convert raw data from Phylogica's financial statements into concise, actionable information that can be used to evaluate the performance of Phylogica over time and compare it to other companies across industries.| Return On Equity | -0.44 | |||
| Return On Asset | -0.26 | |||
| Beta | 0.31 |
Phylogica Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Phylogica's current stock value. Our valuation model uses many indicators to compare Phylogica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Phylogica competition to find correlations between indicators driving Phylogica's intrinsic value. More Info.Phylogica Limited is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Phylogica's earnings, one of the primary drivers of an investment's value.Phylogica Limited Systematic Risk
Phylogica's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Phylogica volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Phylogica Limited correlated with the market. If Beta is less than 0 Phylogica generally moves in the opposite direction as compared to the market. If Phylogica Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Phylogica Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Phylogica is generally in the same direction as the market. If Beta > 1 Phylogica moves generally in the same direction as, but more than the movement of the benchmark.
Phylogica December 14, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Phylogica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Phylogica Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Phylogica Limited based on widely used predictive technical indicators. In general, we focus on analyzing Phylogica Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Phylogica's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1222 | |||
| Maximum Drawdown | 904.86 |
Additional Tools for Phylogica Stock Analysis
When running Phylogica's price analysis, check to measure Phylogica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phylogica is operating at the current time. Most of Phylogica's value examination focuses on studying past and present price action to predict the probability of Phylogica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phylogica's price. Additionally, you may evaluate how the addition of Phylogica to your portfolios can decrease your overall portfolio volatility.